ModelEdge
Scinai Immunotherapeutics Ltd
SCNI
Filing type
20-F
Filing date
May 6, 2025
Updated
May 7, 2025 ยท 5:42 AM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-1.1ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTDEX-2.3DESCRIPTION OF SHARE CAPITALEX-4.3COMPENSATION POLICYEX-4.15AMENDMENT NO. 1 TO LEASE AGREEMENT, DATED APRIL 29, 2022 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)EX-4.16AMENDMENT NO. 2 TO LEASE AGREEMENT, DATED JUNE 3, 2023 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)EX-4.17AMENDMENT NO. 3 TO LEASE AGREEMENT, DATED JULY 10, 2023 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)EX-4.18AMENDMENT NO. 4 TO LEASE AGREEMENT, DATED DECEMBER 15, 2024 (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)EX-4.19AMENDMENT NO. 5 TO LEASE AGREEMENT, DATED DECEMBER 24, 2024. (UNOFFICIAL TRANSLATION FROM HEBREW ORIGINAL)EX-4.29BINDING OPTION AGREEMENT CONCERNING THE SALE AND TRANSFER OF ALL QUOTA IN PINCELL S.R.L. BETWEEN MR. CARLO PINCELLI, MR. ANTONINO AMATO, MRS. ALESSANDRA MARCONI, MRS. ROBERTA LOTTI, MR. BRYDON BENNETT, MS. STEFANIA POLI, PINCELL S.R.L.EX-8.1LIST OF SUBSIDIARIES OF THE COMPANYEX-11.2INSIDER TRADING POLICYEX-12.1CERTIFICATIONEX-12.2CERTIFICATIONEX-13.1CERTIFICATIONEX-13.2CERTIFICATIONEX-15.1CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANTEX-15.2CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANTGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic